Your shopping cart is empty

Subscriber login

Advanced Search

Return to the main site

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Generic Line > Apotex, Pfizer Latest to Reach Deal Allowing Generic Lipitor Launch

Generic Line

March 14, 2012 | Vol. 29 No. 6

Apotex, Pfizer Latest to Reach Deal Allowing Generic Lipitor Launch

Apotex and Pfizer have settled patent litigation on blockbuster Lipitor and the generic-drug maker could launch its copycat version as early as May 30 if it gets FDA approval.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Cephalon’s Fentora Patents Upheld But Court OKs Watson’s Generic Federal Circuit Upholds Cephalon’s Fentora Patents But Says Watson’s Generic Doesn’t Infringe Horizon Sues Par to Protect Arthritis Drug Duexis Watson’s Sanctura Generic OK’d As Court Denies Allergan’s Appeal

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.